Samarendra Mohanty | President and Chief Scientific Officer
Nanoscope Therapeutics

Samarendra Mohanty, President and Chief Scientific Officer, Nanoscope Therapeutics

Dedicated to transforming scientific discoveries into life-changing therapies, Dr. Samarendra Mohanty co-founded Nanoscope Therapeutics and serves as President and Chief Scientific Officer. With over 20 years of experience in biomedical sciences, Dr. Mohanty has co-founded several biotech and medical device companies focused on developing and commercializing innovative diagnostics and therapeutic technologies. His mission-driven work bridges cutting-edge science and patient impact, with a focus on neurological and ophthalmic disorders. Dr. Mohanty holds an M.Tech in Applied Optics from IIT Delhi and a PhD in (Bio)Physics from IISc Bangalore. He has held senior academic and research positions worldwide and is Principal Investigator for major NIH-funded projects, including the Audacious Goal Initiative. With over 200 international patents and publications in top journals like Nature, Dr. Mohanty remains a leader in biomedical innovation. His work has earned him multiple honors, including the NIH Director’s Innovator Award and the Retinal Organoid Challenge Award.

Appearances:



Advanced Therapies USA 2026 - Day 1 @ 11:50

Disease agnostic gene therapy for neurodegenerative conditions

Advanced Therapies USA 2026 - Day 2 @ 09:45

Keynote Panel Discussion: Where’s the Money? Evolution And Future Outlook for Investment in Advanced Therapies

last published: 11/Jun/26 17:55 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Nicholas Matthews
Nicholas.Matthews@terrapinn.com
+44 7495 338515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+02034332221